Abstract

Short Communication

HBV: Genomic Structure, HBVsAg Isolation and innovative Virotherapy Initiation in the Middle East

Aboul-Ata E Aboul-Ata*, Essam M Janahi, I M El-Kalamawy, Kathleen Hefferon and Amal Mahmoud

Published: 09 August, 2017 | Volume 1 - Issue 2 | Pages: 059-061

Hepatitis B virus (HBV) is one of the world’s major infectious diseases with 350 million people who are chronic carriers of HBV [1]. Significant minorities go on to develop liver cirrhosis or hepatocellular carcinoma and over 1 million die annually from HBV-diseased liver. Janahi E. at faculty of science, Bahrain University, Bahrain has submitted the following information [2], on HBV-genome organization as part of his Ph.D. degree (2007) in Imperial College, England. HBV genomic organization has 4 Open Reading Frames (ORFs) i.e. Pre-S/S Gene, Pre-C/C ORF, P ORF and X ORF. Regulatory Elements has 4 promoters (pre S2, pre S1, C promoters and X promoters), Pregenomic RNA, Enhancers (Enh 1 and Enh 2) where they are involved in cccDNA formation, Glococorticoid-Responsive Element which is located in X ORF and P ORF overlapping, Polyadenylation Signal (Direct Repeat 1 (DR1) and Direct Repeat 2 (DR2)), Epsilon-Stem Loop and Post-Transcriptional Regulatory Element. HBV genotype D is prevalent in our Middle East area. The HBV genome is a partially relaxed-circular dsDNA molecule consisting of a full length strand (minus strand) with a single unique nick and a complementary (positive strand) of variable length. HBV is considered as a para-retrovirus because its replication involves the reverse transcription of an intermediate-RNA function, of pre-genomic RNA (pgRNA). Replication of HBV genome starts with the encapsidation of the pgRNA and encodes HBV polymerase into an immature nucleocapsid formed by the viral core antigen.

Read Full Article HTML DOI: 10.29328/journal.jpsp.1001007 Cite this Article Read Full Article PDF

References

  1. Aboul-Ata E Aboul-Ata, Antonella Vitti, Maria Nuzzaci, Ahmad K. El-Attar, Giuseppina 779 Piazzolla‡, et al. Plant-Based Vaccines: Novel and Low-CostPossible Route. For Mediterranean Innovative Vaccination Strategies. Advances in Virus Research. 2014; 89: 1-35.
  2. Janahi EM, Hepatitis B virus. thesis. Imperial Collage of Science. 2007.
  3. Elghannam MS, Attia AS, Shoeb HA, Hashem AM. Expression and purification of hepatitis B surface antigen S from Escherichia coli; a new simple method. BMC Res Notes. 2012; 5: 125-134. Ref.: https://goo.gl/Wj2VX2
  4. El Kalamawy IM, El haddad S, Swelim MA, Hamdy SM, Hanan Molecular variability of S gene of Hepatitis B Virus in Egypt. International J of Virology. 2011; 7: 109-115.
  5. Mahmoud Amal, Hashem MH. Bioinformatics analysis of polymerase and envelope genes of hepatitis B virus in Egypt. Egyptian J Virol. 2014; 11: 32-37. Ref.: https://goo.gl/b23S4b
  6. Hefferon Kathleen. DNA virus Vectors for Vaccine Production in Plants: Spotlight on Geminiviruses. Vaccines (Basel). 2014; 2: 642-653. Ref.: https://goo.gl/xUzkT2
  7. Huang Z, Chen Q, Hjelm B, Arntzen C, Mason H. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng. 2009; 103: 706-714. Ref.: https://goo.gl/sb1JTx
  8. Pniewski T, Kapusta J, Bocia˛g P, Wojciechowicz J, Kostrzak A, et al. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablets formulation. J Appl Genet. 2011; 52: 125-136. Ref.: https://goo.gl/pmHbwA
  9. Pniewski T, Kapusta J, Bociag P, Kostrzak A, Fedorowicz-Strońska O, et al. Plant expression, lyophilisation and storage of HBV medium and large surface antigens for a prototype oral vaccine formulation. Plant Cell Rep. 2012; 31: 585-595. Ref.: https://goo.gl/WxUgx2

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?